|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Total revenue | |||||
| Costs and expenses | |||||
| Cost of sales | |||||
| Research and development | |||||
| Selling, general, and administrative | |||||
| Depreciation and amortization | |||||
| Restructuring charges | |||||
| Total costs and expenses | |||||
| Loss from operations | |||||
| Other income | |||||
| Interest and other income, net | |||||
| Net Loss before income taxes | |||||
| Income tax (expense) benefit | |||||
| Net Loss | |||||
| Net Loss Per Share of Common Stock, Basic (in dollars per share) | |||||
| Net Loss Per Share of Common Stock, Diluted (in dollars per share) | |||||
| Weighted Average Shares of Common Stock Outstanding, Basic (in shares) | |||||
| Weighted Average Shares of Common Stock Outstanding, Diluted (in shares) | |||||
| Non-cash stock-based compensation included in cost of sales and operating expenses | |||||
| Non-cash stock-based compensation included in cost of sales | |||||
| Non-cash stock-based compensation included in research and development | |||||
| Non-cash stock-based compensation included in selling, general and administrative | |||||
| Share-based Compensation |
Loading...